diaceutics plc said wednesday that it has been approved for enhanced access to medical data claims by the us federal agency the centers for medicare  medicaid services or cms the ukbased diagnostics company said that data will be received at an increased frequency and will be integrated with its weekly aggregated lab data in its dxrx diagnostic commercialization platform this will provide customers a near realtime insight into the testing landscape and therefore drive faster access to treatment of patients the company said we have been working with the team at cms for many years and this step up in data access helps supercharge our service in the market chief executive peter keeling said shares at 0954 gmt were up 05 pence or 05 at 990 pence